Ann: Quarterly Activities Report and Appendix 4C, page-4

amb,

TheAqua Phase acquisition is the game changer for Bod if the due diligence results - due late this month-- are successful.

Multi multi bag potential and I have been accumulating since pre rights issue. A rerate is coming.

Regarding your cannabis comparisons--- growers are having a real tough time, with lower demand than expected, competitors squeezing margins and rising costs, ---

Interestingly you have missed one of the best performing plays in this sector NTI, but I view it more as a Biotech play, which I believe will be an absolute standout in the new year.

Bod looks real cheap and if your not set before the Aqua phase results, you may miss the boat. ---(if they're good )

Just a believer.